Origin of Transthyretin in Cerebral Amyloid Angiopathy

Toshiya Nomura; Yohei Misumi; Masayoshi Tasaki; Konen Obayashi; Taro Yamashita; Yukio Ando; Mitsuharu Ueda

doi:10.1001/jamaneurol.2023.5762

Origin of Transthyretin in Cerebral Amyloid Angiopathy

JAMA Neurol. 2024 Feb 26;81(4):421-423. doi: 10.1001/jamaneurol.2023.5762. Online ahead of print.

Authors

Toshiya Nomura¹, Yohei Misumi¹, Masayoshi Tasaki^{1

2}, Konen Obayashi³, Taro Yamashita⁴, Yukio Ando⁵, Mitsuharu Ueda¹

Affiliations

¹ Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
² Department of Biomedical Laboratory Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
³ Department of Morphological and Physiological Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
⁴ Department of Neurology, Soyo Hospital, Kumamoto, Japan.
⁵ Department of Amyloidosis Research, Nagasaki International University, Nagasaki, Japan.

PMID: 38407867
PMCID: PMC10897820 (available on 2025-02-26)
DOI: 10.1001/jamaneurol.2023.5762

No abstract available

Plain language summary

This case series evaluates the correlation between transthyretin and cerebral amyloid angiopathy progression in individuals with hereditary transthyretin amyloidosis.